Identification of a Val 145 Ile substitution in the human myelin oligodendrocyte glycoprotein: Lack of association with multiple sclerosis

Multiple Sclerosis

Volumn 3, Issue 6, 1997, Pages 377-381

  Rodriguez, D ^a,e   Della Gaspera, B ^a   Zalc, B ^b   Haum, J J ^b   Fontaine, B ^b   Edan, G ^c   Clanet, M ^d   Dautigny, A ^a   Pham Dinh, D ^a,e   Baumann, N ^f   Bureau, J F ^f   Cambon Thomsen, A ^f   Clerget Darpoux, F ^f   Confavreux, C ^f   Feingold, J ^f   Heinzlef, O ^f   Lebon, P ^f   Liblau, R ^f   Lyon Caen, O ^f   Pelletier, J ^f   Rieger, F ^f   Both, M P ^f   Boullet, P ^f   Schuller, E ^f   Semana, G ^f   Tournier Lasserve, E ^f   Vuillemin, C ^f   Yaouanq, J ^f   more..

^a CNRS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CHU PURPAN   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

^f NONE

Author keywords

Association study; Genetic susceptibility; Multiple sclerosis; Myelin; Polymorphism

Indexed keywords

ANTIGEN; ARGININE; DNA; GLYCOPROTEIN; GUANOSINE; ISOLEUCINE; MEMBRANE PROTEIN; MYELIN; RESTRICTION ENDONUCLEASE; VALINE; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ARTICLE; AUTOIMMUNE DISEASE; CODON; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXON; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PATHOGENICITY; PATIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MUTATION; MYELIN-ASSOCIATED GLYCOPROTEIN; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0031474720     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300603     Document Type: Article

References (30)

1. Gardinier MV, Amiguet P, Linington C, Matthieu JM. (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the imunoglobulin superfamily. J Neurosci Res 33: 177-187.
2. Pham-Dinh D et al. (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90: 7990-7794.
3. Birling MC, Roussel G, Nussbaum F, Nussbaum JL. (1993) Biochemical and immunohistochemical studies with specific polyclonal antibodies directed against bovine myelin/oligodendrocyte glycoprotein. Neurochem Res 18: 937-945.
4. Kroepfl JF et al. (1996) Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J Neurochem 67: 2219-2222.
5. Scolding NJ et al. (1989) Myelin-oligodendrocyte glyco-protein is a surface marker of oligodendrocyte maturation. J Neuroimmunol 22: 169-176
6. Brunner C et al. (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligoden-droglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296-304.
7. Solly SK et al. (1996) MOG expression is associated with myelin deposition. Glia 18: 39-48.
8. Linington C et al. (1993) T cells specific for myelin/ oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364-1372.
9. Johns TG et al. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154: 5536 -5541.
10. Kerlero de Rosbo N, Mendel I, Ben-Nun A. (1995) Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin-oligodendrocyte glycoprotein (MOG)-derived peptide: Preliminary analysis of MOG T cell epitopes. Eur J Immunol 15: 985-993.
11. Kerlero de Rosbo N et al. (1993) Reactivity to myelin antigens in multiple sclerosis: peripheral blood lymphocytes respond predominantly to myelin/oligodendrocyte glycoprotein gene (MOG). J Clin Invest 6: 2602-2608.
12. Hauser SL. (1994) Multiple sclerosis and other demyelinating diseases. In Harrison's Principles of Internal Medicine, Isselbacher K et al. (eds), 13th ed. McGraw-Hill, New-York pp 2287-2295.
13. Ebers GC, Canadian Collaborative Study. (1995) A genetic basis for familial aggregation in multiple sclerosis. Nature 377: 150-151.
14. Sawcer S et al. (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 13: 464-468.
15. Haines JL, The Multiple Sclerosis Study Genetics Group. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 13: 469-471.
16. Ebers GC et al. (1996) A full genome search in multiple sclerosis. Nature Genet 13: 471-476.
17. Olerup O, Hillert J. (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38: 1-15.
18. Pham-Dinh D et al. (1994) Cloning and expression of the human myelin/oligodendrocyte glycoprotein cDNA. J Neurochem 63: 2353-2356.
19. Hilton AA, Slavin AJ, Hilton DJ, Bernard CCA (1995) Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J Neurochem 65: 309-318.
20. Pham-Dinh D, Della Gaspera B, Kerlero de Rosbo N, Dautigny A. (1995) Human myelin/oligodendrocyte glycoprotein gene: alternative splicing generates multiple isoforms. Genomics 29: 345-352.
21. Roth MP et al. (1995) The human myelin oligodendrocyte glycoprotein (MOG) gene: complete nucleotide sequence and structural characterization. Genomics 28: 241-250.
22. Amadou G et al. (1995) Localization of new genes and markers to the distal part of the human Major Histocompatibility Complex (MHC) region and comparison with the mouse: new insights into the evolution of mammalian genomes. Genomics 26: 9-20.
23. Pham-Dinh D et al. (1995b) Physical mapping of human and mouse MOG gene at the distal end of the MHC class 1b region. Immunogenetics 42: 386-391.
24. Steinmann L. (1993) Connections between the immune system and the nervous system. Proc Natl Acad Sci USA 90: 7912-7914.
25. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis : guidelines for research protocols. Ann Neural 13: 227-231.
26. Sambrook J, Fritsch EF, Maniatis T. (1989) Molecular cloning: a laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Charcot JM. (1868) Histologie de la Sclérose en Plaques. Gaz Hop (Paris) 41: 554-566
28. Raine C. (1983) Multiple sclerosis and chronic relapsing EAE: comparative ultrastructural neuropathology. In Multiple Sclerosis. Pathology, Diagnosis and Management. JF Hallpike, GWM Adams and WW Tourtelotte (eds). William and Wilkins Co., Baltimore pp 413-460.
29. Genain CP et al. (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274: 2054-2057.
30. Roth MP et al. (1995) Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG. J Neuroimmunol 61: 117-122.